Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colorectal Neoplasms × Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 5 Uterine Cervical Neoplasms 2 Influenza, Human 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Recurrence 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Medullary cystic kidney disease 1 1 Lung Neoplasms 1 Glioblastoma 1 Epstein-Barr Virus Infections 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Condylomata Acuminata 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Anus Neoplasms 1 Anal Canal Carcinoma 1

Interventions

Bevacizumab 200 Fluorouracil 193 Irinotecan 187 Oxaliplatin 183 Leucovorin 174 Capecitabine 129 Cetuximab 124 Panitumumab 61 Folfox protocol 42 regorafenib 38 Radiotherapy 36 IFL protocol 34 pembrolizumab 33 HMPL-013 30 trifluridine tipiracil drug combination 26 Nivolumab 26 Neoadjuvant Therapy 23 Drug Therapy 20 tislelizumab 16 Celecoxib 16 aflibercept 14 XELOX 14 Chemotherapy, Adjuvant 14 sintilimab 13 atezolizumab 13 Trifluridine 13 Trastuzumab 13 Gemcitabine 13 durvalumab 12 Floxuridine 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06522919 2025-01-28

CombiCoR-Vax

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡